MB Clinical Research

09/15/2025

https://icont.ac/517nV

2025 Focused Update of the ESC/EAS Guidelines for the Management of Dyslipidemias Since the release of the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) Guidelines for the Management of Dyslipidemias, several new randomized controlled trials related to dyslipidemia...

06/16/2025

Volume 9 Issue 2 of the MB Clinical Research Newsletter posted below

https://icont.ac/513Lt

03/24/2025

Volume 9 issue 1 of the MB Clinical Research Newsletter is posted below:

https://icont.ac/50ZSQ

12/03/2024

Volume 8 issue 4 of the MB Clinical Research Newsletter posted below:

https://icont.ac/50UtN

09/23/2024

https://icont.ac/50hZ8
Volume 8 issue 3 of the MB Clinical Research Newsletter posted below:

Intensive low-density lipoprotein cholesterol (LDL-C) lowering with proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors added to statin therapy has been shown to substantially reduce atherosclerotic cardiovascular disease (ASCVD) events.1-3 Furthermore, results from the Effects of the P...

07/01/2024

Volume 8 issue 2 of the MB Clinical Research Newsletter posted below:
https://icont.ac/4Z7Yt

03/21/2024

Volume 8 issue 1 of the MB Clinical Research Newsletter posted below:
https://icont.ac/4XfcF

12/26/2023

Volume 7 issue 4 of the MB Clinical Research Newsletter posted below:
https://icont.ac/4Vukl

10/06/2023

Volume 7 Issue 3 of the MB Clinical Research Newsletter posted below:
https://icont.ac/4TWt0

07/03/2023

Volume 7 issue 2 of the MB Clinical Research Newsletter posted below:
https://icont.ac/4RI16

03/24/2023

Volume 7 issue 1 of the MB Clinical Research Newsletter is posted below, thanks.
http://icont.ac/4PNAd

11/28/2022

Volume 6 Issue 4 of the MB Clinical Research Newsletter is posted below
http://www.icontact-archive.com/archive?c=197599&f=9569&s=16081&m=970665&t=6d87218b58f118ac7f4f0801551488636853bc3a3e2b728a22adc1b101c835c0